Study S000775

Safety and Efficacy of Tirzepatide (Spartina) in Obese Kidney Transplant Recipients: A Pilot Study on Weight Loss, Gastrointestinal Tolerability, and Graft Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07423247
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2026-01-01
Primary completion: 2026-07
Lead sponsor: Shahid Beheshti University of Medical Sciences
Conditions: Tirzepatide
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percent Change in Body Weight From Baseline at Week 24 [Baseline to Week 24]
Incidence of Gastrointestinal Adverse Events [Baseline to Week 24 (monthly assessment)]
Change in Serum Creatinine [Baseline to Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.